Mantinas BioPharma Holdings Inc., a biopharmaceutical company based in Bedminster, has appointed Keith A. Kucinski as its new chief financial officer, it announced Thursday.
“As we look to drive our company forward in 2019 and maximize the value of our products and platform technology, we have taken deliberate steps to bolster our management team over the past few months. I am thrilled to have Keith join, adding his highly complementary expertise at such a critical time. I believe the depth and breadth of his experience will provide the necessary financial leadership as we work to propel Matinas through its next stage of growth. Keith has played key roles in successful companies throughout his career and his steady hand and strategic thinking were instrumental in unlocking significant value for shareholders,” CEO Jerome D. Jabbour said.
Kucinski has more than 20 years of experience in the finance industry, most recently serving as chief financial officer at RemedyOne. Before that, he served as vice president and treasurer at Par Pharmaceutical Companies Inc. Additionally, he held various roles at Barr Pharmaceuticals Inc., including senior director, finance and corporate development, and assistant treasurer and senior director, finance.
“Matinas has experienced exciting momentum over the course of 2018. I believe that there is significant upside potential here, and I look forward to leveraging my 20 years’ experience and working closely with Jerry and the rest of the management team to unlock the Company’s value in the near term,” Kucinski said.
